Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 390(4): 1288-93, 2009 Dec 25.
Article in English | MEDLINE | ID: mdl-19878649

ABSTRACT

PCSK9 (Proprotein Convertase Subtilisin Kexin type 9) is a proprotein convertase that plays a key role in cholesterol homeostasis by decreasing hepatic low-density lipoprotein receptor (LDLR) protein expression. Here, we investigated the expression and the function of PCSK9 in pancreatic islets. Immunohistochemistry analysis showed that PCSK9 co-localized specifically with somatostatin in human pancreatic delta-cells, with no expression in alpha- and beta-cells. PCSK9 seems not to be secreted by mouse isolated islets maintained in culture. Pcsk9-deficiency led to a 200% increase in LDLR protein content in mouse isolated islets, mainly in beta-cells. Conversely, incubation of islets with recombinant PCSK9 almost abolished LDLR expression. However, Pcsk9-deficiency did not alter cholesterol content nor glucose-stimulated insulin secretion in mouse islets. Finally, invivo glucose tolerance was similar in Pcsk9(+/+) and Pcsk9(-/-) mice under basal conditions and following streptozotocin treatment. These results suggest, at least in mice, that PCSK9 does not alter insulin secretion.


Subject(s)
Insulin-Secreting Cells/metabolism , Insulin/metabolism , Serine Endopeptidases/biosynthesis , Somatostatin-Secreting Cells/enzymology , Animals , Cell Line , Cholesterol/metabolism , Glucose/metabolism , Glucose/pharmacology , Humans , Insulin Secretion , Insulin-Secreting Cells/drug effects , Mice , Proprotein Convertase 9 , Proprotein Convertases , Receptors, LDL/metabolism , Serine Endopeptidases/genetics , Somatostatin-Secreting Cells/drug effects
2.
BMC Physiol ; 3: 13, 2003 Oct 22.
Article in English | MEDLINE | ID: mdl-14572315

ABSTRACT

BACKGROUND: Amylin (islet amyloid polypeptide) is a hormone with suggested roles in the regulation of glucose homeostasis, gastric motor and secretory function and gastroprotection. In the gastric mucosa amylin is found co-localised with somatostatin in D-cells. The factors regulating gastric amylin release are unknown. In this study we have investigated the regulation of amylin release from gastric mucosal cells in primary culture. Rabbit fundic mucosal cells enriched for D-cells by counterflow elutriation were cultured for 40 hours. Amylin and somatostatin release over 2 hours in response to agonists were assessed. RESULTS: Amylin release was significantly enhanced by activation of protein kinase C with phorbol-12-myristate-13-acetate, adenylate cyclase with forskolin and elevation of intracellular calcium with A23187. Cholecystokinin (CCK), epinephrine and glucagon-like peptide-1 (GLP-1) each stimulated amylin release in a dose-dependent manner. Maximal CCK-stimulated release was greater than either epinephrine or GLP-1, even when the effects of the latter two were enhanced by isobutylmethylxanthine. Stimulated amylin release was significantly inhibited by carbachol (by 51-59%) and octreotide (by 33-42%). Somatostatin release paralleled that of amylin. CONCLUSIONS: The cultured D-cell model provides a means of studying amylin release. Amylin secretion is stimulated by receptor-dependent and -independent activation of Ca2+/protein kinase C and adenylate cyclase pathways. Inhibition involves activation of muscarinic receptors and auto-regulation by somatostatin.


Subject(s)
Amyloid/metabolism , Gastric Fundus/metabolism , Gastric Mucosa/metabolism , Adenylyl Cyclases/physiology , Amyloid/antagonists & inhibitors , Animals , Cells, Cultured , Cholecystokinin/physiology , Gastric Fundus/cytology , Gastric Fundus/drug effects , Gastric Fundus/enzymology , Gastric Mucosa/cytology , Gastric Mucosa/drug effects , Gastric Mucosa/enzymology , Homeostasis/physiology , Islet Amyloid Polypeptide , Octreotide/pharmacology , Protein Kinase C/physiology , Rabbits , Receptors, Cholecystokinin/physiology , Somatostatin/analogs & derivatives , Somatostatin/metabolism , Somatostatin/pharmacology , Somatostatin/physiology , Somatostatin-Secreting Cells/chemistry , Somatostatin-Secreting Cells/drug effects , Somatostatin-Secreting Cells/enzymology , Somatostatin-Secreting Cells/metabolism
3.
J Histochem Cytochem ; 48(6): 839-46, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10820157

ABSTRACT

gamma-Aminobutyric acid (GABA) is a neurotransmitter that also occurs in a few non-neuronal cell types, where it may serve as a paracrine modulator. GABA is biosynthesized from glutamate by glutamate decarboxylase (GAD) and from putrescine via diamine oxidase (DAO). GAD is demonstrable in several GABA-positive cell types but is undetectable in the GABA-containing gastrin cells and somatostatin cells of the antropyloric mucosa of the stomach. Using two antisera raised against synthetic peptides corresponding to two different regions of rat DAO, we now demonstrate strong reactivity for DAO in gastrin-positive cells of the rat antropyloric mucosa, whereas somatostatin-positive cells as well as other structures of the antrum are unreactive. Western blotting analysis of antrum and colon demonstrate that both antisera react with a single band of 85 kD, consistent with the predicted molecular weight of DAO. Expression of DAO mRNA in the antrum is demonstrated by reverse transcriptase polymerase chain reaction (RT-PCR). Our results strongly indicate that gastrin cells produce GABA via DAO-catalyzed oxidation of putrescine, and experimental data moreover suggest that the biosynthesis of GABA is regulated by the prandial state. Because GABA modulates release of somatostatin, these results point to a new mechanism of paracrine interaction between gastrin cells and somatostatin cells.


Subject(s)
Amine Oxidase (Copper-Containing)/metabolism , Gastrin-Secreting Cells/enzymology , Pyloric Antrum/enzymology , gamma-Aminobutyric Acid/biosynthesis , Amine Oxidase (Copper-Containing)/genetics , Amino Acid Sequence , Animals , Blotting, Western/methods , Catalysis , Colon/cytology , Colon/enzymology , Female , Fluorescent Antibody Technique, Indirect , Gastric Mucosa/cytology , Gastric Mucosa/enzymology , Gastrin-Secreting Cells/cytology , Gastrins/analysis , Guinea Pigs , Male , Molecular Sequence Data , Pyloric Antrum/cytology , Rabbits , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction/methods , Somatostatin/analysis , Somatostatin-Secreting Cells/cytology , Somatostatin-Secreting Cells/enzymology
4.
FEBS Lett ; 415(3): 281-4, 1997 Oct 06.
Article in English | MEDLINE | ID: mdl-9357983

ABSTRACT

We immunohistochemically examined the distribution of glucokinase in rat pancreatic islets. Glucokinase immunoreactivity under light microscopy was detected in the cytoplasm of somatostatin cells as well as in that of insulin cells. No specific immunoreactivity was detected in glucagon and pancreatic polypeptide cells. In somatostatin cells, glucokinase immunoreactivity was located by electron microscopy exclusively within secretory granules.


Subject(s)
Cytoplasmic Granules/enzymology , Glucokinase/analysis , Somatostatin-Secreting Cells/enzymology , Animals , Glucagon/analysis , Immunohistochemistry , Insulin/analysis , Islets of Langerhans/chemistry , Islets of Langerhans/cytology , Islets of Langerhans/enzymology , Male , Microscopy, Electron , Pancreatic Polypeptide/analysis , Rats , Rats, Wistar , Somatostatin/analysis , Somatostatin-Secreting Cells/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...